ReIGNITE Therapeutics
PrivateLast Round
Accelerator
Apr 1, 2025
Total Funding Raised
$1.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ReIGNITE Therapeutics operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was an Accelerator round in April 2025.
ReIGNITE Therapeutics is a biotechnology company that leverages directed evolution to engineer next-generation viral vectors for oncolytic immunotherapies and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ReIGNITE Therapeutics Comparables
Compare ReIGNITE Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adze Biotechnology | 81% | |
| VacV Biotherapeutics | 80% | |
| KaliVir Immunotherapeutics | 79% |
For institutional investors. Book with your work email.
ReIGNITE Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Apr 1, 2025 | ||||
| Corporate Funding | Mar 1, 2024 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 31% MoM.
- Jun 22, 2026
Monthly visitors increased 61% MoM.
For institutional investors. Book with your work email.
ReIGNITE Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ReIGNITE Therapeutics's valuation, stock price, and market status.
Is ReIGNITE Therapeutics a public or private company?
ReIGNITE Therapeutics is a private company.
What is the current stock price of ReIGNITE Therapeutics?
ReIGNITE Therapeutics is a private company, so its shares have no public market price. Caplight tracks ReIGNITE Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ReIGNITE Therapeutics worth (valuation)?
Valuation information for ReIGNITE Therapeutics is not publicly available.
Can I buy ReIGNITE Therapeutics stock?
ReIGNITE Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ReIGNITE Therapeutics's last funding round?
ReIGNITE Therapeutics's most recent funding round was Accelerator on April 1, 2025.
Who are the main investors in ReIGNITE Therapeutics?
Investor information for ReIGNITE Therapeutics is not publicly disclosed.
Will ReIGNITE Therapeutics IPO soon?
No public IPO plans have been announced for ReIGNITE Therapeutics.
How can I track ReIGNITE Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in ReIGNITE Therapeutics's shares on secondary markets.